Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone
- PMID: 8567178
- DOI: 10.1111/j.1399-3011.1995.tb01068.x
Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone
Abstract
ShK-toxin, a 35 residue peptide isolated from the sea anemone Stichodactyla helianthus, was synthesized using an Fmoc strategy and successfully folded to the biologically active form containing three intramolecular disulfide bonds. The ability of synthetic ShK toxin to inhibit specific [125I]-dendrotoxin I binding to rat brain membranes slightly exceeded (was more potent than) that of the natural ShK toxin sample, but was comparable with previously reported data for ShK toxin. The peptide toxin inhibited [125I]-charybdotoxin binding to Jurkat T lymphocytes with an IC50 value of 32 pM. In addition, Jurkat T lymphocytes Kv1.3 potassium channels were inhibited with an IC50 value of 133 pM. Owing to their unique structure and high affinity for at least some potassium channels, ShK toxin and related sea anemone potassium channel toxins may become useful molecular probes for investigating potassium channels.
Similar articles
-
A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity.Eur J Biochem. 1997 Feb 15;244(1):192-202. doi: 10.1111/j.1432-1033.1997.00192.x. Eur J Biochem. 1997. PMID: 9063464
-
Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.Biochemistry. 1999 Nov 2;38(44):14549-58. doi: 10.1021/bi991282m. Biochemistry. 1999. PMID: 10545177
-
Designed peptide analogues of the potassium channel blocker ShK toxin.Biochemistry. 2001 Dec 25;40(51):15528-37. doi: 10.1021/bi011300b. Biochemistry. 2001. PMID: 11747428
-
Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases.Curr Med Chem. 2004 Dec;11(23):3041-52. doi: 10.2174/0929867043363947. Curr Med Chem. 2004. PMID: 15578998 Review.
-
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.Inflamm Allergy Drug Targets. 2011 Oct;10(5):313-21. doi: 10.2174/187152811797200641. Inflamm Allergy Drug Targets. 2011. PMID: 21824083 Free PMC article. Review.
Cited by
-
Biochemical and electrophysiological characterization of two sea anemone type 1 potassium toxins from a geographically distant population of Bunodosoma caissarum.Mar Drugs. 2013 Mar 6;11(3):655-79. doi: 10.3390/md11030655. Mar Drugs. 2013. PMID: 23466933 Free PMC article.
-
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.Toxicon. 2012 Oct;60(5):840-50. doi: 10.1016/j.toxicon.2012.05.017. Epub 2012 May 31. Toxicon. 2012. PMID: 22659540 Free PMC article.
-
A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3.MAbs. 2018 May/Jun;10(4):636-650. doi: 10.1080/19420862.2018.1445451. Epub 2018 Apr 2. MAbs. 2018. PMID: 29494279 Free PMC article.
-
Venom-Derived Peptide Modulators of Cation-Selective Channels: Friend, Foe or Frenemy.Front Pharmacol. 2019 Feb 26;10:58. doi: 10.3389/fphar.2019.00058. eCollection 2019. Front Pharmacol. 2019. PMID: 30863305 Free PMC article. Review.
-
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.Toxicon. 2012 Mar 15;59(4):529-46. doi: 10.1016/j.toxicon.2011.07.016. Epub 2011 Aug 12. Toxicon. 2012. PMID: 21867724 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases